International Society for Molecular Neurodegeneration (ISMND) 2024 Conference ¹× 2024³â Á¦16ȸ ´ëÇÑÅðÇ༺½Å°æÁúȯÇÐȸ Çмú´ëȸ DAY 1 : 2024-05-27
±³À°ÀÏÀÚ : 2024-05-27
±³À°Àå¼Ò : ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£
±³À°ÁÖÁ¦ : International Society for Molecular Neurodegeneration (ISMND) 2024 Conference ¹× 2024³â Á¦16ȸ ´ëÇÑÅðÇ༺½Å°æÁúȯÇÐȸ Çмú´ëȸ DAY 1
ÁÖÃÖ±â°ü : ´ëÇѽŰæ°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑÅðÇ༺½Å°æÁúȯÇÐȸ
´ã´çÀÚ : µµÀμ÷
¿¬¶ôó : 02-6677-0534
À̸ÞÀÏ : office@ismnd2024.org
±³À°Á¾·ù : ½Å°æ°ú
Âü¼®¿¹»óÀÎ : 400¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 950,000¿ø
ºñ°í ISMND ȸ¿ø - Professional: 600,000¿ø / Postdocs/Fellows/Residents: 300,000¿ø / Students: 100,000¿øISMND ºñȸ¿ø - Professional: 950,000¿ø / Postdocs/Fellows/Residents: 450,000¿ø / Students: 250,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05¿ù 27ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 08:50~09:05 When and where does Alzheimer¡¯s disease start? Colin Masters(The Florey Institute/University of Melbourne)
±³À°½Ã°£ 05¿ù 27ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 09:05~09:20 Exploring the diversity of molecular mechanisms underlying Parkinson Ted Dawson(Johns Hopkins University)
±³À°½Ã°£ 05¿ù 27ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 09:20~09:35 Molecular pathology of Alzheimer Takeshi Iwatsubo(The University of Tokyo)
±³À°½Ã°£ 05¿ù 27ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 09:35~09:50 From molecular mechanisms to development of targeted therapies for neurodegenerative disorders Dimitri Krainc(Northwestern University)
Åä·Ð 05¿ù 27ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 09:50~10:10 Q&As ( )
ÈÞ½Ä 05¿ù 27ÀÏ ÄÁÆÛ·±½º·ë(³²) 4Ãþ ·Îºñ ¹× 402È£ 10:10~10:40 Coffee Break / Exhibits ( )
±³À°½Ã°£ 05¿ù 27ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 10:40~10:55 Genetics of late-onset Alzheimer¡¯s disease implicates a causal role of efferocytosis Alison Goate(Icahn School of Medicine at Mount Sinai)
±³À°½Ã°£ 05¿ù 27ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 10:55~11:10 Alzheimer¡¯s disease informed by rare genetic mutations Rudolph Tanzi(Harvard Medical School/Massachusetts General Hospital)
±³À°½Ã°£ 05¿ù 27ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 11:10~11:25 Plasma biomarkers for predicting the microglial phagocytic function in neurodegenerative diseases ±è½ÂÇö(ÇѾçÀÇ´ë)
±³À°½Ã°£ 05¿ù 27ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 11:25~11:40 Tracking immune changes in dementia using body fluid biomarkers Charlotte Teunissen(Amsterdam University Medical Center)
Åä·Ð 05¿ù 27ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 11:40~12:00 Q&As ( )
½Ä»ç 05¿ù 27ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 12:00~13:30 Lunch Break / Exhibits ( )
±³À°½Ã°£ 05¿ù 27ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 13:30~13:45 Gut-Neuron Communication in Longevity Regulation Meng Wang(Janelia Research Campus)
±³À°½Ã°£ 05¿ù 27ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 13:45~14:00 Gut-brain axis in Alzheimer ¹¬ÀÎÈñ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 05¿ù 27ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 14:00~14:15 Role of the gut microbiome in modulation of AD-like pathology in mouse models Sangram Sisodia(University of Chicago)
±³À°½Ã°£ 05¿ù 27ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 14:15~14:30 Exploring the impact of cellular senescence on brain aging and neurodegeneration Miranda Orr(Wake Forest University)
±³À°½Ã°£ 05¿ù 27ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 14:30~14:45 Sphingolipid metabolism in Alzheimer ÁøÈñ°æ(°æºÏ´ë)
Åä·Ð 05¿ù 27ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 14:45~15:10 Q&As ( )
ÈÞ½Ä 05¿ù 27ÀÏ ÄÁÆÛ·±½º·ë(³²) 4Ãþ ·Îºñ ¹× 402È£ 15:10~15:40 Coffee Break / Exhibits ( )
Åä·Ð 05¿ù 27ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 16:40~17:20 Panel Discussion I: Biomarkers and Therapeutic Strategies Colin Masters Henrietta Nielsen Takeshi Iwatsubo Charlotte Teunissen ±è½ÂÇö(The Florey Institute/University of Melbourne Stockholms University The University of Tokyo Amsterdam University Medical Center ÇѾçÀÇ´ë)